Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 5:2:1276982.
doi: 10.3389/frabi.2023.1276982. eCollection 2023.

A brief insight into Citrobacter species - a growing threat to public health

Ishrat Jabeen  1 , Sohidul Islam  1 , A K M Imrul Hassan  1 , Zerin Tasnim  1 , Sabbir R Shuvo  1
Affiliations
Review

A brief insight into Citrobacter species - a growing threat to public health

Ishrat Jabeen et al. Front Antibiot. .

Abstract

Citrobacter spp. are Gram-negative, non-spore forming, rod-shaped, facultative anaerobic bacteria from the Enterobacteriaceae family often found in soil, sewage, sludge, water, food, and the intestinal tracts of animals and humans. Several members of Citrobacter spp. especially C. freundii, C. koseri, C. braakii are frequently detected in newborn illnesses, urinary tract infections, and patients with severe underlying conditions, including hypertension, diabetes, cancer, and respiratory infections, or those who are immunocompromised. Strains of Citrobacter spp. can spread vertically or horizontally from carriers or other hospital sources and thus cause nosocomial infections in hospital settings. A total of 19 Citrobacter genomospecies have been recognized based on genomics. It has been noted that the Citrobacter genus acquired antimicrobial resistance and virulence, including invasion, colonization, biofilm formation, and toxin production. The recent emergence and spread of antimicrobial resistance to β-lactams, carbapenems, fluoroquinolones, aminoglycosides, and colistin in Citrobacter spp. through chromosomal and plasmid-mediated resistance limits the empiric treatment options. Therefore, combination therapy involving costly and potentially hazardous antibiotics poses significant challenges in treating Citrobacter infections. Here we summarized the nomenclature of Citrobacter spp., clinical manifestations, epidemiology, pathogenesis, antibiotic resistance mechanisms, and treatments from various clinical samples. This review will expand our knowledge of the genomics and epidemiology of Citrobacter spp., enabling improved control of infections and the spread of these organisms.

Keywords: Citrobacter spp.; epidemiology; multidrug resistance; pathogenesis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Phylogenetic analysis of 19 Citrobacter spp. The branches display the percentage of trees where related groups of species clustered together. The evolutionary tree was constructed using the Maximum Likelihood technique in the MEGA X software (Kumar et al., 2018). The tree was visualized using Interactive Tree of Life (iTOL).
Figure 2
Figure 2
Heat map of the 118 virulence proteins across 18 different Citrobacter spp. studied. Dark brown squares denote the presence of the genes, and grey squares denote the absence of the genes listed.
Figure 3
Figure 3
Heat map of 86 antibiotic resistant genes across the reference genomes of 18 different Citrobacter spp. studied were predicted using CARD database (Alcock et al., 2020) Dark blue squares denote the presence of the genes and grey squares denote the absence of the genes listed.
See this image and copyright information in PMC

References

    1. Abady N. R., Abdul S., Salman K. (2021). Antimicrobial effect of silver nanosilver particles on multi-drug resistant isolates of kluyvera cryocrescens and Citrobacter freundii . Ann. Romanian Soc. Cell Biol. 25, 6687–6701.
    1. Aguirre-Sánchez J. R., Quiñones B., Ortiz-Muñoz J. A., Prieto-Alvarado R., Vega-López I. F., Martínez-Urtaza J., et al. (2023). Comparative genomic analyses of virulence and antimicrobial resistance in Citrobacter werkmanii, an emerging opportunistic pathogen. Microorganisms 11, 1–17. doi: 10.3390/microorganisms11082114 - DOI - PMC - PubMed
    1. Alcock B. P., Raphenya A. R., Lau T. T. Y., Tsang K. K., Bouchard M., Edalatmand A., et al. (2020). CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517–D525. doi: 10.1093/nar/gkz935 - DOI - PMC - PubMed
    1. Arana D. M., Ortega A., González-Barberá E., Lara N., Bautista V., Gómez-Ruíz D., et al. (2017). Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2. J. Antimicrob. Chemother. 72, 3283–3287. doi: 10.1093/jac/dkx325 - DOI - PubMed
    1. Ashish K., Singh N., Aggarwal A., Khanna M. (2012). The antibiotic resistance pattern in citro-bacter species: an emerging nosocomial pathogen in a tertiary care hospital. J. Clin. Diagn. Res. 6, 642–644.

LinkOut - more resources